Invitrogen, Thermo Fisher, SAIC-Frederick, Silicon Kinetics, Sigma-Aldrich, Hybrigenics, Strategic Diagnostics, Advanced Proteome | GenomeWeb
Bio-Discovery Up as Invitrogen Posts 14.8 Percent Spike in Q3 Revs
Invitrogen this week reported receipts of $361.7 million in its third quarter, up 14.8 percent from $315 million a year ago. That includes a 13.2 percent increase in its Bio-Discovery segment, which houses its proteomics tools and consumables, to $249.4 million from $220.4 million a year ago.
Cell Systems, Invitrogen’s other segment, saw revenues grow to $112.3 million, up 18.7 percent from $94.6 million a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.